Page last updated: 2024-10-28

miltefosine and Laryngeal Diseases

miltefosine has been researched along with Laryngeal Diseases in 1 studies

miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.

Laryngeal Diseases: Pathological processes involving any part of the LARYNX which coordinates many functions such as voice production, breathing, swallowing, and coughing.

Research Excerpts

ExcerptRelevanceReference
"His dysphonia was initially managed as bronchiectasis with little improvement."1.43Laryngeal leishmaniasis in a patient taking inhaled corticosteroids. ( Mukherjee, J; Phillips, D; Roberts, RM, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Roberts, RM1
Mukherjee, J1
Phillips, D1

Other Studies

1 other study available for miltefosine and Laryngeal Diseases

ArticleYear
Laryngeal leishmaniasis in a patient taking inhaled corticosteroids.
    BMJ case reports, 2016, Jun-21, Volume: 2016

    Topics: Administration, Inhalation; Adrenal Cortex Hormones; Aged; Antiemetics; Antiprotozoal Agents; Asthma

2016